{
    "clinical_study": {
        "@rank": "85480", 
        "arm_group": [
            {
                "arm_group_label": "Active", 
                "arm_group_type": "Experimental", 
                "description": "NWP09"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Placebo"
            }
        ], 
        "brief_summary": {
            "textblock": "The safety and efficacy of a chewable formulation of extended-release methylphenidate will\n      be studied in children with ADHD"
        }, 
        "brief_title": "NWP09 in Children With Attention Deficit Hyperactivity Disorder (ADHD)", 
        "completion_date": {
            "#text": "October 2012", 
            "@type": "Actual"
        }, 
        "condition": "Attention Deficit Hyperactivity Disorder", 
        "condition_browse": {
            "mesh_term": [
                "Attention Deficit Disorder with Hyperactivity", 
                "Hyperkinesis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Children aged 6 to 12 years with ADHD who require pharmacologic treatment for this\n             condition\n\n        Exclusion Criteria:\n\n          -  Other serious illnesses or conditions that would put the patient at particular risk\n             for safety events or would interfere with treatment/assessment of ADHD"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "12 Years", 
            "minimum_age": "6 Years"
        }, 
        "enrollment": {
            "#text": "90", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "April 27, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01654250", 
            "org_study_id": "NWP09-ADHD-300", 
            "secondary_id": "B7491005"
        }, 
        "intervention": [
            {
                "arm_group_label": "Active", 
                "description": "Methylphenidate, variable dose, daily dosing, 1 week duration", 
                "intervention_name": "NWP09", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo", 
                "description": "Placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Methylphenidate"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "ADHD", 
            "methylphenidate extended-release"
        ], 
        "lastchanged_date": "November 5, 2013", 
        "link": {
            "description": "To obtain contact information for a study center near you, click here.", 
            "url": "https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=NWP09-ADHD-300&StudyName=NWP09%20in%20Children%20with%20Attention%20Deficit%20Hyperactivity%20Disorder%20%28ADHD%29"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Little Rock", 
                        "country": "United States", 
                        "state": "Arkansas", 
                        "zip": "72211"
                    }, 
                    "name": "Clinical Study Centers, LLC"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Huntington Beach", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92646"
                    }, 
                    "name": "Laboratory School"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Irvine", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92697"
                    }, 
                    "name": "UC Irvine - Hewitt Hall"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Irvine", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92612"
                    }, 
                    "name": "UC Irvine Child Development Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bradenton", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "34201"
                    }, 
                    "name": "Florida Clinical Research Center, LLC"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bradenton", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "34202"
                    }, 
                    "name": "Woodland Community Church (Laboratory School)"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Las Vegas", 
                        "country": "United States", 
                        "state": "Nevada", 
                        "zip": "89128"
                    }, 
                    "name": "Center for Psychiatry and Behavioral Medicine, Inc."
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77007"
                    }, 
                    "name": "Bayou City Research, Ltd."
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lubbock", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "79423"
                    }, 
                    "name": "Westex Clinical Investigations"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Multicenter, Dose-optimized, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy of NWP09 in Pediatric Patients With Attention Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom", 
        "overall_official": {
            "affiliation": "Pfizer", 
            "last_name": "Pfizer CT.gov Call Center", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "October 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "measure": "Clinical Global Impression - Improvement (CGI-I) at X Months", 
                "safety_issue": "No", 
                "time_frame": "7 weeks"
            }, 
            {
                "measure": "Mean Clinical Global Impression - Severity (CGI-S) score", 
                "safety_issue": "No", 
                "time_frame": "7 weeks"
            }, 
            {
                "measure": "SKAMP-combined", 
                "safety_issue": "No", 
                "time_frame": "1 day"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01654250"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "PERM-P", 
                "safety_issue": "No", 
                "time_frame": "1 day"
            }, 
            {
                "measure": "Conners Parent rating Scale", 
                "safety_issue": "No", 
                "time_frame": "2 days"
            }
        ], 
        "source": "Pfizer", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Pfizer", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "July 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}